Security Snapshot

First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) Institutional Ownership

CUSIP: 33733E203

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

277

Shares (Excl. Options)

3,442,050

Price

$206.52

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
Symbol
FBT
Shares outstanding
11,300,576
Price per share
$200.82
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,442,050
Total reported value
$711,049,226
% of total 13F portfolios
0%
Share change
+391,456
Value change
+$83,057,696
Number of holders
277
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund is tracked under CUSIP 33733E203.
  • 277 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 277 to 75 between Q4 2025 and Q1 2026.
  • Reported value moved from $711,049,226 to $65,114,233.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 277 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 33733E203?
CUSIP 33733E203 identifies FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FIRST TRUST PORTFOLIOS LP 32% $754,049,493 3,651,216 First Trust Portfolios L.P. 31 Jan 2026

As of 31 Dec 2025, 277 institutional investors reported holding 3,442,050 shares of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT). This represents 30% of the company’s total 11,300,576 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 3.6% 401,201 +18% 0% $82,856,229
LPL Financial LLC 2.3% 260,833 +30% 0.01% $53,867,294
BANK OF AMERICA CORP /DE/ 1.7% 190,106 +0.48% 0% $39,260,724
WELLS FARGO & COMPANY/MN 1.7% 188,584 +2.7% 0.01% $38,946,547
UBS Group AG 1.7% 187,088 +17% 0.01% $38,637,414
ROYAL BANK OF CANADA 1.4% 154,869 +1.4% 0.01% $31,984,000
RAYMOND JAMES FINANCIAL INC 1.3% 145,659 +5.9% 0.01% $30,081,473
Berger Financial Group, Inc 1% 114,950 -0.47% 1.4% $23,739,396
ENVESTNET ASSET MANAGEMENT INC 1% 114,657 -5.2% 0.01% $23,678,938
360 Financial, Inc. 0.64% 72,085 4.5% $14,886,994
Stonebridge Financial Group, LLC 0.63% 71,346 1.3% $14,734,376
Janney Montgomery Scott LLC 0.62% 70,054 +139% 0.03% $14,468,000
Cetera Investment Advisers 0.56% 62,870 +19% 0.01% $12,984,183
STIFEL FINANCIAL CORP 0.53% 60,446 +16% 0.01% $12,483,632
TRUIST FINANCIAL CORP 0.49% 55,228 +22% 0.02% $11,405,783
OSAIC HOLDINGS, INC. 0.47% 52,887 -4.7% 0.02% $10,924,808
D.A. DAVIDSON & CO. 0.44% 49,772 +27% 0.06% $10,278,914
ASSETMARK, INC 0.41% 46,560 +15% 0.02% $9,615,571
AMERIPRISE FINANCIAL INC 0.4% 45,546 -0.26% 0% $9,411,709
TWO SIGMA INVESTMENTS, LP 0.38% 42,700 +278% 0.01% $8,818,404
Modern Wealth Management, LLC 0.37% 41,578 +1.2% 0.16% $8,586,633
Cambridge Investment Research Advisors, Inc. 0.34% 38,161 +3.2% 0.02% $7,881,000
BENJAMIN EDWARDS INC 0.27% 30,480 -3.6% 0.07% $6,301,908
Kestra Advisory Services, LLC 0.27% 30,277 +69% 0.03% $6,252,825
Ameritas Advisory Services, LLC 0.26% 29,901 +12411% 0.23% $6,175,079

Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 323,833 $65,114,233 -$9,386,737 $200.82 75
2025 Q4 3,442,050 $711,049,226 +$83,057,696 $206.52 277
2025 Q3 3,042,011 $545,834,448 -$11,896,976 $179.29 252
2025 Q2 3,155,408 $509,245,856 -$41,077,763 $161.33 247
2025 Q1 3,418,328 $576,824,224 +$1,866,805 $170.12 266
2024 Q4 3,418,857 $568,580,158 +$41,645,148 $166.21 253
2024 Q3 3,143,605 $540,228,542 -$50,274,497 $171.93 252
2024 Q2 3,468,418 $534,289,452 +$6,575,921 $153.99 247
2024 Q1 3,399,038 $522,621,545 -$94,532,990 $153.77 240
2023 Q4 4,017,594 $634,837,157 -$30,986,867 $158.06 254
2023 Q3 4,190,296 $613,262,596 -$62,820,801 $146.35 239
2023 Q2 4,617,487 $707,129,055 -$19,966,454 $153.14 247
2023 Q1 4,700,385 $728,635,260 -$18,428,171 $155.03 241
2022 Q4 4,877,768 $751,529,554 +$55,433,739 $154.13 239
2022 Q3 4,496,690 $593,813,874 +$22,209,350 $131.98 212
2022 Q2 4,332,609 $587,753,929 -$18,206,139 $135.56 218
2022 Q1 4,448,675 $663,407,924 -$82,106,064 $149.14 212
2021 Q4 4,955,742 $802,113,791 -$46,741,875 $161.96 239
2021 Q3 5,178,909 $859,978,174 -$14,178,042 $166.06 230
2021 Q2 5,220,166 $900,985,426 -$80,585,265 $172.62 227
2021 Q1 5,725,862 $919,195,735 -$21,822,779 $160.50 232
2020 Q4 5,809,688 $976,622,166 -$78,183,499 $167.99 232
2020 Q3 6,096,208 $959,021,765 -$32,144,151 $157.26 210
2020 Q2 6,226,658 $1,045,067,619 +$191,623,157 $167.77 222
2020 Q1 5,157,697 $676,659,157 -$47,084,204 $131.12 193
2019 Q4 5,487,562 $816,287,431 -$74,667,369 $148.72 207
2019 Q3 5,992,894 $742,538,774 -$882,858,217 $123.76 184
2019 Q2 12,569,930 $1,770,181,894 +$35,822,419 $140.84 217
2019 Q1 12,360,195 $1,864,503,721 +$128,595,965 $150.85 224
2018 Q4 11,657,169 $1,449,690,480 -$403,797,433 $124.20 190
2018 Q3 14,181,041 $2,246,741,087 +$1,432,250,063 $158.49 187
2018 Q2 5,133,431 $718,724,343 +$63,854,991 $140.01 154
2018 Q1 4,683,224 $622,474,212 +$91,611,191 $132.90 152
2017 Q4 3,984,755 $496,314,617 +$44,748,999 $124.57 126
2017 Q3 3,605,567 $446,754,001 +$14,480,513 $123.93 115
2017 Q2 3,492,182 $398,275,105 +$56,018,406 $114.04 112
2017 Q1 3,018,492 $316,695,674 -$4,736,324 $105.30 113
2016 Q4 3,095,489 $281,588,359 +$13,238,858 $90.87 107
2016 Q3 2,930,364 $291,496,084 -$4,711,885 $99.71 110
2016 Q2 3,076,251 $274,668,626 -$39,232,497 $89.43 105
2016 Q1 3,349,153 $294,129,961 -$1,892,206,413 $87.56 102
2015 Q4 21,779,226 $2,459,415,016 +$164,656,445 $113.02 127
2015 Q3 20,090,644 $2,036,625,833 +$162,029,493 $101.32 126
2015 Q2 18,456,703 $2,288,765,259 +$285,028,551 $124.02 123
2015 Q1 16,117,838 $1,905,196,132 +$443,224,811 $118.23 119
2014 Q4 12,339,312 $1,258,885,285 +$245,972,458 $102.02 109
2014 Q3 9,633,125 $883,813,866 +$85,577,040 $91.78 95
2014 Q2 8,789,399 $715,910,314 +$32,118,674 $82.33 92
2014 Q1 8,321,792 $638,198,251 +$51,685,578 $76.69 81